Quantcast

Latest Antidepressant Stories

2014-06-24 08:29:42

Pharmacogenomic test now available to help guide clinicians' medication decisions for veterans being treated for mental health conditions MASON, Ohio, June 24, 2014 /PRNewswire/ -- Assurex Health today announced that the U.S. Department of Veterans Affairs (VA) has approved its Federal Supply Schedule (FSS) contract as a government supplier, effective June 15, 2014, making the GeneSight(®) Psychotropic test available for use in VA facilities nationwide. The Veterans Health...

2014-06-23 12:29:42

Data Highlight Physician and Payer Receptivity to Emerging Agents for Treatment-Resistant Depression, According to Findings from Decision Resources Group BURLINGTON, Mass., June 23, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed U.S. psychiatrists are receptive to novel adjunctive therapies to antidepressants for treatment-resistant depression (TRD) and would prescribe Otsuka/Lundbeck's emerging atypical antipsychotic brexpiprazole to a mean 12 percent of their drug-treated...

Tablet with a medicine
2014-06-19 10:33:25

Brett Smith for redOrbit.com - Your Universe Online In an attempt to raise awareness about a potential increased risk of suicide tied to antidepressant use, health officials may have made inadvertently made the problem worse. According to a new study in the British Medical Journal, FDA warnings about the increased risk of suicide and subsequent media coverage in 2003 were followed by a sudden drop in the number of prescriptions for antidepressants without compensation through increases...

2014-06-19 08:28:31

The New Website Offers Visitors Information About SSRIs and Autism, Autism Diagnoses, and How to Receive Compensation for Being Prescribed Autism-Inducing Medications HOUSTON, June 19, 2014 /PRNewswire-iReach/ -- Danziger & De Llano, LLP, a law firm whose main focus is to obtain justice for injured victims and their families, recently announced the launch of its new website, http://www.nationalautismclaims.com/. The law firm's latest site aims to provide help to children...

2014-06-17 13:13:51

American Society of Anesthesiologists Fast-acting ketamine by-product may be future therapy for Alzheimer's, Parkinson's There is new hope for people suffering from depression. Researchers have identified a compound, hydroxynorketamine (HNK), that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study in the July issue of Anesthesiology, the official medical journal of...

2014-06-17 08:30:31

Takeda and Lundbeck Announce Results at American Society of Clinical Psychopharmacology Annual Meeting HOLLYWOOD, Fla., June 17, 2014 /PRNewswire/ -- Takeda Pharmaceuticals Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced that the companies will present results about sexual functioning from a head-to-head study of Brintellix(®) (vortioxetine) vs. escitalopram in patients with well treated major depressive disorder (MDD) experiencing treatment-emergent sexual...

2014-06-12 12:26:31

Lack of Disease-Modifying Therapies is Expected to Remain a Critical Unmet Need and Provides Ample Opportunity for Developers, According to Findings from Decision Resources Group BURLINGTON, Mass., June 12, 2014 /PRNewswire/ -- Decision Resources Group finds that three therapies, Teva's Huntexil, Auspex's SD-809 and Raptor's Procysbi, will likely receive regulatory approval for Huntington's disease (HD) in the United States and the EU5 markets (Germany, France, Italy, Spain and United...

2014-06-12 11:13:10

University of Oxford The recent recession can be linked with over 10,000 suicides across Europe and North America between 2008 and 2010 The recent recession can be linked with over 10,000 suicides across Europe and North America between 2008 and 2010, according to research by the University of Oxford and the London School of Hygiene & Tropical Medicine. The findings, published in the British Journal of Psychiatry, show that suicide rates rose significantly in the EU, Canada and the...

2014-06-10 23:03:31

The GlaxoSmithKline settlement involves the District of Columbia and 44 states over the marketing of Advair, Paxil, and Wellbutrin. Port Washington, NY (PRWEB) June 10, 2014 Parker Waichman LLP, a national law firm representing the victims of defective drugs is commenting on a recent settlement by drug maker, GlaxoSmithKline, over allegations involving the way in which Advair, Paxil, and Wellbutrin were marketed and how the drugs were promoted for off-label uses. According to a The...

depression brain molecule
2014-06-09 04:40:57

redOrbit Staff & Wire Reports - Your Universe Online Levels of a tiny molecule known as miR-1202 are lower in the brains of people suffering from depression, suggesting that it could serve as a marker for depression and help detect which patients are most likely to respond to antidepressant treatment, experts from McGill University and the Douglas Institute claim in a new study. Their research, which has been published by the journal Nature Medicine, shows that miR-1202 could...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related